With three years behind schedule and after overcoming major setbacks, such as the fall of a cantilever, the Center for Public Health Research yesterday finally opened its doors nearly six years after he put the first stone of the building. Along the way, these plants have lost their purely scientific to cede much of its units to accommodate staff related to the area of Public Health currently working in the headquarters of the Ministry of Health in Valencia. Or integrate disaggregated laboratories, such as those in Albal.
One of the projects pursued a vaccine against tooth decay
Among the main areas of research, the center has a department of vaccines, which work in the development of new compounds. Already there are projects underway to find preparations immunized against meningitis B, or an essay about bird flu in children. Another of the open lines, in this case in the area of genomics and health, is the search for a vaccine against tooth decay. In addition, the facility opened yesterday by the President of the Generalitat, Francisco Camps, Valencia will coordinate the network of biobanks. In six years, aims to house 100,000 samples of plasma, serum and DNA from patients suffering from various diseases. The idea is to have a database of quality that can be put at the service of researchers to compare the characteristics of these samples with those of healthy population and in-depth study of these diseases.
In addition, the center will have areas of molecular epidemiology, health inequalities and pharmacoepidemiology. One of the other fields of study are rare diseases, whose face is Francisco Palau, scientific director of the Center for Biomedical Research on Rare Diseases Network, based in Valencia.
The Center for Public Health is the last of the great centers of health research driven by the Generalitat with European funds. The first to go into operation was the Senior Center Prince Felipe, biomedicine, which has a strong research base. The second is the one that manages the Mediterranean Ophthalmic Center, which combines research with the nursing care patients with the most derivative of public health.
One of the projects pursued a vaccine against tooth decay
Among the main areas of research, the center has a department of vaccines, which work in the development of new compounds. Already there are projects underway to find preparations immunized against meningitis B, or an essay about bird flu in children. Another of the open lines, in this case in the area of genomics and health, is the search for a vaccine against tooth decay. In addition, the facility opened yesterday by the President of the Generalitat, Francisco Camps, Valencia will coordinate the network of biobanks. In six years, aims to house 100,000 samples of plasma, serum and DNA from patients suffering from various diseases. The idea is to have a database of quality that can be put at the service of researchers to compare the characteristics of these samples with those of healthy population and in-depth study of these diseases.
In addition, the center will have areas of molecular epidemiology, health inequalities and pharmacoepidemiology. One of the other fields of study are rare diseases, whose face is Francisco Palau, scientific director of the Center for Biomedical Research on Rare Diseases Network, based in Valencia.
The Center for Public Health is the last of the great centers of health research driven by the Generalitat with European funds. The first to go into operation was the Senior Center Prince Felipe, biomedicine, which has a strong research base. The second is the one that manages the Mediterranean Ophthalmic Center, which combines research with the nursing care patients with the most derivative of public health.
No comments:
Post a Comment